{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:32:37Z","timestamp":1767108757293,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.arcmed.2007.11.012","type":"journal-article","created":{"date-parts":[[2008,2,15]],"date-time":"2008-02-15T07:53:39Z","timestamp":1203062019000},"page":"338-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Single Nucleotide Polymorphisms in the Hypoxia-inducible Factor-1\u03b1 (HIF-1\u03b1) Gene in Human Sporadic Breast Cancer"],"prefix":"10.1016","volume":"39","author":[{"given":"Isil","family":"Apaydin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ece","family":"Konac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Ilke","family":"Onen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Akbaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ercument","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Ekmekci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2007.11.012_bib1","first-page":"74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.arcmed.2007.11.012_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-5122(00)00196-1","article-title":"Breast cancer: hormones and other risk factors","volume":"38","author":"Hulka","year":"2001","journal-title":"Maturitas"},{"key":"10.1016\/j.arcmed.2007.11.012_bib3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1056\/NEJMra050776","article-title":"Estrogen carcinogenesis in breast cancer","volume":"354","author":"Yager","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arcmed.2007.11.012_bib4","first-page":"4010","article-title":"Hypoxia-inducible factor-1\u03b1 is a positive factor in solid tumor growth","volume":"60","author":"Ryan","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2007.11.012_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0955-0674(00)00194-0","article-title":"HIF-1 and mechanisms of hypoxia sensing","volume":"13","author":"Semenza","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.arcmed.2007.11.012_bib6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.arcmed.2007.11.012_bib7","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.11.012_bib8","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/82146","article-title":"Suppression of tumor growth through disruption of hypoxia-inducible transcription","volume":"6","author":"Kung","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.arcmed.2007.11.012_bib9","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2007.11.012_bib10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9440(10)64554-3","article-title":"The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages","volume":"157","author":"Talks","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcmed.2007.11.012_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jnci\/93.4.309","article-title":"Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis","volume":"93","author":"Bos","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.arcmed.2007.11.012_bib12","first-page":"1830","article-title":"Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy","volume":"61","author":"Koukourakis","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2007.11.012_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.lungcan.2006.05.025","article-title":"C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein expression in non-small cell lung cancer","volume":"53","author":"Koukourakis","year":"2006","journal-title":"Lung Cancer"},{"issue":"suppl 1","key":"10.1016\/j.arcmed.2007.11.012_bib14","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1677\/erc.1.01290","article-title":"Role of hypoxia-inducible factor-1alpha as a cancer therapy target","volume":"13","author":"Patiar","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2007.11.012_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/00129785-200101030-00005","article-title":"Finding genes influencing susceptibility to complex diseases in the post-genome era","volume":"1","author":"Rannala","year":"2001","journal-title":"Am J Pharmacogenomics"},{"key":"10.1016\/j.arcmed.2007.11.012_bib16","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1210\/jc.2005-0991","article-title":"Genetic variation in the hypoxia-inducible factor-1 alpha gene is associated with type 2 diabetes in Japanese","volume":"90","author":"Yamada","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2007.11.012_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/bmme.1997.2627","article-title":"Sequence analysis of the 3\u2032 hypoxia-responsive element of the human erythropoietin gene in patients with erythrocytosis","volume":"62","author":"Percy","year":"1997","journal-title":"Biochem Mol Med"},{"key":"10.1016\/j.arcmed.2007.11.012_bib18","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/carcin\/bgg132","article-title":"Hypoxia-inducible factor-1 alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance","volume":"24","author":"Tanimoto","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.arcmed.2007.11.012_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-4598-5-3","article-title":"Hypoxia-inducible factor-1 alpha polymorphisms and TSC1\/2 mutations are complementary in head and neck cancers","author":"Hebert","year":"2006","journal-title":"Mol Cancer"},{"key":"10.1016\/j.arcmed.2007.11.012_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cancergencyto.2004.01.014","article-title":"Polymorphisms in the hypoxia inducible factor-1 alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype","volume":"153","author":"Ollerenshaw","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.arcmed.2007.11.012_bib21","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4161\/cbt.4.11.2091","article-title":"Polymorphism in the hypoxia-inducible factor 1 alpha gene may confer susceptibility to androgen-independent prostate cancer","volume":"4","author":"Chau","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.arcmed.2007.11.012_bib22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/mc.20209","article-title":"Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients","volume":"45","author":"Fransen","year":"2006","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.arcmed.2007.11.012_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cdp.2007.01.001","article-title":"An investigation of relationships between hypoxia-inducible factor-1\u03b1 gene polymorphisms and ovarian, cervical and endometrial cancers","volume":"31","author":"Konac","year":"2007","journal-title":"Cancer Detect Prevent"},{"key":"10.1016\/j.arcmed.2007.11.012_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10549-006-9408-4","article-title":"A multigenic approach to predict breast cancer risk","volume":"104","author":"Gerger","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.arcmed.2007.11.012_bib25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ijc.11238","article-title":"A common 936 C\/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk","volume":"106","author":"Krippl","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.arcmed.2007.11.012_bib26","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.bjc.6600625","article-title":"Role of genetic polymorphisms in tumour angiogenesis","volume":"87","author":"Balasubramanian","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.arcmed.2007.11.012_bib27","first-page":"840","article-title":"Cancer progression and tumor cell motility are associated with the FGFR4 Arg (388) allele","volume":"62","author":"Bange","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2007.11.012_bib28","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1200\/JCO.2005.04.8587","article-title":"FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer","volume":"24","author":"Thussbas","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2007.11.012_bib29","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/clinchem\/46.12.2023","article-title":"MMP1 and MMP3 polymorphisms in promoter regions and cancer","volume":"46","author":"Biondi","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.arcmed.2007.11.012_bib30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/1097-0142(20010215)91:4<672::AID-CNCR1050>3.0.CO;2-J","article-title":"Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70\u20132: susceptibility and prognostic implications in breast carcinoma","volume":"91","author":"Mestiri","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.arcmed.2007.11.012_bib31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cyto.2005.01.007","article-title":"A functional polymorphism of the tumor necrosis factor receptor-II gene associated with the survival and relapse prediction of breast carcinoma","volume":"30","author":"Mestiri","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.arcmed.2007.11.012_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.18388\/abp.2000_4077","article-title":"Plasminogen activator inhibitor-1 (PAI-1) gene 4G\/5G promoter polymorphism is not associated with breast cancer","volume":"47","author":"B\u0142asiak","year":"2000","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.arcmed.2007.11.012_bib33","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/cncr.11246","article-title":"Levels of hypoxia-inducible factor-1\u03b1 independently predict prognosis in patients with lymph node negative breast cancer","volume":"97","author":"Bos","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.arcmed.2007.11.012_bib34","article-title":"Association of polymorphisms of angiogenesis genes with breast cancer","author":"Schneider","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.arcmed.2007.11.012_bib35","first-page":"1033","article-title":"Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma","volume":"12","author":"Kuwai","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1016\/j.arcmed.2007.11.012_bib36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10549-006-9292-y","article-title":"Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women","volume":"102","author":"Slattery","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.arcmed.2007.11.012_bib37","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1677\/erc.1.00728","article-title":"Hypoxia-inducible factor-1 in human breast and prostate cancer","volume":"13","author":"Kimbro","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2007.11.012_bib38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/0008-5472.CAN-06-2701","article-title":"Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression","volume":"67","author":"Liao","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2007.11.012_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1476-4598-2-31","article-title":"A common polymorphism in the oxygen-dependent degradation (ODD) domain of hypoxia inducible factor-1alpha (HIF-1alpha) does not impair Pro-564 hydroxylation","volume":"2","author":"Percy","year":"2003","journal-title":"Mol Cancer"},{"key":"10.1016\/j.arcmed.2007.11.012_bib40","first-page":"cm8","article-title":"Hypoxia-inducible factor 1 (HIF-1) pathway","volume":"407","author":"Semenza","year":"2007","journal-title":"Sci STKE"},{"key":"10.1016\/j.arcmed.2007.11.012_bib41","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1074\/jbc.M610415200","article-title":"Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF","volume":"282","author":"Koivunen","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2007.11.012_bib42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/path.1029","article-title":"Expression of HIF-1 by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy","volume":"196","author":"Burke","year":"2002","journal-title":"J Pathol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440907004134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440907004134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:36:13Z","timestamp":1759260973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440907004134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0188440907004134"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2007.11.012","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single Nucleotide Polymorphisms in the Hypoxia-inducible Factor-1\u03b1 (HIF-1\u03b1) Gene in Human Sporadic Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2007.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}